Research Snappy
  • Market Research Forum
  • Investment Research
  • Consumer Research
  • More
    • Advertising Research
    • Healthcare Research
    • Data Analysis
    • Top Companies
    • Latest News
No Result
View All Result
Research Snappy
No Result
View All Result

Activities of Daily Living and Life-Space Mobility in Older Adults wit

researchsnappy by researchsnappy
January 9, 2020
in Healthcare Research
0
Quality Of Life And Stigma Among People Living With HIV/AIDS In Iran
399
SHARES
2.3k
VIEWS
Share on FacebookShare on Twitter

Isabel Fialho Fontenele Garcia,1 Carina Tiemi Tiuganji,1 Maria do Socorro Morais Pereira Simões,2 Adriana Claudia Lunardi1,3

1Master’s and Doctoral, Programs in Physical Therapy, Universidade Cidade de São Paulo, São Paulo, SP, Brazil; 2Department of Human Movement Sciences, Universidade Federal de São Paulo, Santos, SP, Brazil; 3Department of Physical Therapy, School of Medicine, Universidade de São Paulo, São Paulo, SP, Brazil

Correspondence: Adriana Claudia Lunardi
Master’s and Doctoral Programs in Physical Therapy, Universidade Cidade de São Paulo, 448/475 Cesário Galeno Street, São Paulo 03071-000, SP, Brazil
Tel +55 11 2178-1310
Fax +55 11 2178-1355
Email [email protected]

Purpose: The aim of this study was to investigate whether limitation during the performance of activities of daily living (ADL) was associated with life-space mobility in older people with chronic obstructive pulmonary disease (COPD), and to generate a regression model for life-space mobility score.
Patients and Methods: This cross-sectional study with a convenience sample included older people (aged ≥60 years old) with COPD. We assessed participants’ lung function (spirometry), life-space mobility (University of Alabama at Birmingham Study of Aging Life-Space Assessment questionnaire), severity of dyspnea (Modified Dyspnea Index) and limitation during the performance of ADL (London Chest Activity of Daily Living). We used Pearson’s correlation to investigate the associations between the measures, and multiple linear regression to detect which of the measures influenced life-space mobility. Statistical significance was set at 5%.
Results: Fifty participants completed all the assessments (29 females [58%]; mean ± SD age of 67 ± 6 years old, FEV1 47 ± 29% of predicted, and body mass index 22.5 ± 11.6 kg/m2). Their mean scores for life-space mobility and for limitation during the performance of ADL were 49.7 ± 27.2 and 16.46 ± 9.74, respectively. We found a strong inverse correlation between limitation during the performance of ADL and life-space mobility (r = −0.57, p = <0.01) as well as between severity of dyspnea and life-space mobility (r= 0.86, p= <0.01). Both sex and limitation during the performance of ADL were considered as independent factors associated to life-space mobility (R2= 0.56).
Conclusion: In this study, limitations during the performance of ADL and dyspnea had a strong correlation with life-space mobility in older adults with COPD. Also, alongside sex, the limitation during the performance of ADL is an independent factor associated with life-space mobility in a regression model.

Keywords: COPD, older adult, mobility limitation, activities of daily living


Creative Commons License
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License.

By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Previous Post

Perficient, Inc. (NASDAQ:PRFT) Given Consensus Recommendation of “Buy” by Brokerages

Next Post

BioMarin Pharmaceutical’s (NASDAQ:BMRN) “Buy” Rating Reaffirmed at Cowen

Next Post
Janney Montgomery Scott LLC Increases Stake in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN)

BioMarin Pharmaceutical’s (NASDAQ:BMRN) “Buy” Rating Reaffirmed at Cowen

Research Snappy

Category

  • Advertising Research
  • Consumer Research
  • Data Analysis
  • Healthcare Research
  • Investment Research
  • News
  • Top Company News

HPIN International Financial Platform Becomes a New Benchmark for India’s Digital Economy

Top 10 Market Research Companies in the world

3 Best Market Research Certifications in High Demand

  • Privacy Policy
  • Terms of Use
  • Antispam
  • DMCA
  • Contact Us

© 2025 researchsnappy.com

No Result
View All Result
  • Market Research Forum
  • Investment Research
  • Consumer Research
  • More
    • Advertising Research
    • Healthcare Research
    • Data Analysis
    • Top Companies
    • Latest News

© 2025 researchsnappy.com